VN1R108P (Gene)

Description:vomeronasal 1 receptor 108 pseudogene

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View VN1R108P's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with VN1R108P.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using VN1R108P.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for VN1R108P.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with VN1R108P.

Results found

Linked to

	Label	Description
	GSE100148 EZH2 inhibition 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228261 FDX1 overexpression WSU-DLCL2 Elesclomol 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE228261 elesclomol WSU-DLCL2 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205976 GSE205978 CEP83 knockout TIME 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE200538 butyrolactone Hep-G2 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119369 H10 inhibition 1 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205976 GSE205978 CEP83 knockout TIME 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 4 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE240444 navitoclax 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 14 v 13 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE100148 EZH2 inhibition 4 v 5 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE228261 FDX1 overexpression WSU-DLCL2 Elesclomol 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE228261 elesclomol WSU-DLCL2 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE205976 GSE205978 CEP83 knockout TIME 2 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE200538 butyrolactone Hep-G2 1 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE119369 H10 inhibition 1 v 9 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE205976 GSE205978 CEP83 knockout TIME 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE100148 EZH2 inhibition 4 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE240444 navitoclax 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE108464 AZ-628 14 v 13 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.